Pharmacy
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
The FINANCIAL -- Merck KGaA, Darmstadt, Germany, and Pfizer Inc. on September 21 announced that the European Commission (EC) has...
The world is running out of antibiotics, WHO report confirms
The FINANCIAL -- A report, Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including...
Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT
The FINANCIAL -- Pfizer Inc. on September 19 announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory...
Novartis drug Rydapt receives EU approval for newly diagnosed FLT3-mutated AML and three types of advanced SM
The FINANCIAL -- Novartis on September 20 announced that the European Commission (EC) approved Rydapt (midostaurin) for two indications in...
Teva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 Billion
The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on September 18 announced it has entered into two agreements to sell the...
Bristol-Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors
The FINANCIAL -- Bristol-Myers Squibb Company on September 13 announced that its Board of Directors has elected Karen Vousden, Ph.D.,...
AstraZeneca and Aspen enter agreement for remaining rights to anaesthetics medicines
The FINANCIAL -- AstraZeneca on September 14 announced that it has entered into an agreement with Aspen Global Incorporated (AGI),...
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI
The FINANCIAL -- Pfizer Inc. and Astellas Pharma Inc. announced on September 14 that the Phase 3 PROSPER trial evaluating...
Teva Receives FDA Priority Review for First Line Use of TRISENOX
The FINANCIAL -- Teva Pharmaceutical Industries Ltd. announced on September 12 the U.S. Food and Drug Administration (FDA) has accepted...
Missed opportunities for big savings from generic drugs in Europe
The FINANCIAL -- Shifting patients from branded to less expensive generic medicines is an important way to contain health care...
Bayer places 9.4 percent stake in Covestro
The FINANCIAL -- Bayer AG has reduced its direct interest in Covestro from 40.9 percent to 31.5 percent.
Wolfgang Nickl to be new Chief Financial Officer at Bayer AG
The FINANCIAL -- The Supervisory Board of Bayer AG has appointed Wolfgang Nickl (48) to the Board of Management of...
Pfizer Presents Overall Survival Data of XALKORI in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer
The FINANCIAL -- Pfizer Inc. on September 11 announced final overall survival (OS) data from the PROFILE 1014 trial examining...
Teva Names Kåre Schultz as President and Chief Executive Officer
The FINANCIAL -- Teva Pharmaceutical Industries Ltd. on September 11 announced that its Board of Directors has named Kåre Schultz...
Roche announces phase III study results of Zelboraf
The FINANCIAL -- Roche on September 11 announced data for the phase III BRIM8 study, which was designed to investigate...
ADVERTISEMENT
Popular Last 24h
-
Minnesota Man Sentenced To 15 Months For Trafficking In Stolen Human Remains
-
Justice Department Files Voting Rights Suit Against City of Hazleton, Pennsylvania
-
Ampersand wins £22m five-year contract at London Zoo
-
How the Aging Brain Affects Thinking
-
Zebra dies after ‘incident’with rhino at zoo
-
ICE Acquires the American Financial Exchange (AFX)
-
Government Contractor Agrees to Pay $1M to Resolve False Claims Act Allegations for Submitting Fraudulent Bids on Prime Vendor Contracts
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
